Table 3 Types and top 3 subtypes of unique DRPs
From: Drug-related problems reported by patients with rheumatic diseases: an observational study
Type | n (% of total) | |
|---|---|---|
Subtype | n (% within type) | |
(Suspected) side effects | 85 (28%) | |
Infection(s) | 7 (8%) | |
Fatigue | 6 (7%) | |
Nausea | 5 (6%) | |
Medication management | 80 (26%) | |
Administering injection | 11 (14%) | |
Storage when travelling | 11 (14%) | |
Intake schedule while travelling | 11 (14%) | |
Medication concerns | 60 (19%) | |
(Long-term) effectiveness | 19 (32%) | |
Drug-use (general) | 17 (28%) | |
(Long-term) side-effects | 8 (13%) | |
Medication effectiveness | 52 (17%) | |
Insufficient effect | 30 (58%) | |
Dose reduction | 14 (27%) | |
Unclear effect | 6 (12%) | |
Information needs | 13 (4%) | |
(Long-term) side-effects | 4 (31%) | |
Mechanism of action | 2 (15%) | |
Infection(s) | 1 (8%) | |
Contra-indications | 9 (3%) | |
Infection(s) | 5 (56%) | |
Pregnancy | 2 (22%) | |
Blood levels | 1 (11%) | |
Logistics | 9 (3%) | |
Availability | 5 (56%) | |
Service | 2 (22%) | |
Reimbursement | 1 (11%) | |